ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 325

Anti-Cyclic Citrullinated Peptide Antibody Isotyping and Identification of Citrullinated Proteins in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients

Brooke Gilliam1, Sandra Crespo-Pagnussat2, Anil K. Chauhan2, Reema H. Syed2 and Terry L. Moore3, 1IM-Rheumatology, Saint Louis University, St. Louis, MO, 2Rheumatology, Saint Louis University, St. Louis, MO, 3Internal Medicine/Rheumatology, Saint Louis University, Saint Louis, MO

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Anti-CCP antibodies and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Several citrullinated proteins have been detected in the serum and synovial fluid (SF) of rheumatoid arthritis (RA) patients. However, few studies have evaluated citrullination of proteins in juvenile idiopathic arthritis (JIA). It has been proposed that anti-cyclic citrullinated peptide (anti-CCP) antibodies play a pathogenic role in the development of anti-CCP antibody positive arthritis, and it is expected that these antibodies would be present at higher concentrations at the site of inflammation. We evaluated SF from JIA patients to investigate the presence of anti-CCP antibody isotypes and identified specific citrullinated autoantibodies in JIA SF.

Methods:

Anti-CCP antibody isotypes (IgA, IgG, IgM, IgA/IgG) were measured by ELISA in the SF of 47 JIA patients. As non-inflammatory controls, SF from 10 osteoarthritis (OA) patients was used. Twenty-four SF samples from patients with various diagnoses were treated and transferred to PVDF membranes and probed with antibodies to native-α enolase, native fibrinogen, and anti-modified citrulline (AMC). SF samples were immunoprecipitated with antibodies to fibrinogen and α-enolase, and citrullinated antibodies were then detected with AMC assay.

Results:

Eleven of 47 (23%) JIA SF samples were positive for at least one anti-CCP antibody isotype. IgM anti-CCP antibodies were positive in 9 JIA patients, IgG anti-CCP antibodies were positive in 8 patients, and 2 were positive for IgA anti-CCP antibodies. Three JIA patients were positive for the combined IgA/IgG anti-CCP antibodies. Polyarthritis patients demonstrated significantly higher levels of all anti-CCP antibody isotypes compared to other JIA subtypes (p<0.05), and even higher levels when only evaluating IgM rheumatoid factor (RF)-positive polyarthritis patients. Serum-matched anti-CCP antibody data was available on 27 JIA patients and 5 controls. All IgM RF-positive polyarthritis patients were positive for IgG anti-CCP antibodies in both serum and SF. Two JIA patients positive for IgG anti-CCP antibodies in SF were negative in serum. More JIA patients were positive for IgA anti-CCP antibodies in serum than in SF, while SF showed increased positivity for IgM anti-CCP antibodies compared to serum.

Western blot analysis revealed multiple citrullinated proteins in JIA that were not detected in OA. Immunoprecipitation with α-enolase and fibrinogen, followed by AMC detection showed presence of these specific citrullinated proteins in JIA and no detection in OA

Conclusion:

All anti-CCP antibodies were detected in the SF of JIA patients. The most commonly found anti-CCP antibody isotype in JIA SF was IgM, which may be partly indicative of defective B cell class switching in these patients. Measurement of only IgG anti-CCP antibodies would have overlooked 4 JIA patients with elevated levels of IgA and/or IgM anti-CCP antibodies, indicating the importance of measuring all 3 isotypes. The abundance of citrullinated proteins in JIA SF may be characteristic of inflammation, as seen in RA and spodyloarthritis. We have shown the detection of citrullinated proteins at the site of inflammation, specifically identifying citrullinated fibrinogen and α-enolase in SF.


Disclosure:

B. Gilliam,
None;

S. Crespo-Pagnussat,
None;

A. K. Chauhan,
None;

R. H. Syed,
None;

T. L. Moore,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anti-cyclic-citrullinated-peptide-antibody-isotyping-and-identification-of-citrullinated-proteins-in-the-synovial-fluid-of-juvenile-idiopathic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology